News tagged with myelofibrosis

Related topics: blood cancer , bone marrow

Improved survival for patients with chronic blood diseases

(Medical Xpress) -- New research from Karolinska Institutet shows that the survival for patients with chronic myeloproliferative diseases has improved in recent decades. This is despite the fact that no targeted drugs have ...

Jul 17, 2012
popularity not rated yet | comments 0

Drug offers relief for symptoms of myelofibrosis

People with a blood cancer — myelofibrosis — can benefit from a drug called ruxolitinib, according to a randomized, double-blind, placebo-controlled clinical trial that included patients and researchers from the ...

Feb 29, 2012
popularity not rated yet | comments 0 | with audio podcast

Britain snubs costly Novartis blood cancer drug

British health authorities said on Wednesday they would not recommend Jakavi, a drug produced by Swiss pharmaceutical company Novartis to treat a rare form of blood cancer, deeming it too expensive.

Feb 13, 2013
popularity not rated yet | comments 0

Myelofibrosis

Myelofibrosis, also known as myeloid metaplasia, chronic idiopathic myelofibrosis, osteomyelofibrosis and primary myelofibrosis is a disorder of the bone marrow. It is currently classified as a myeloproliferative disease in which the proliferation of an abnormal type of bone marrow stem cell results in fibrosis, or the replacement of the marrow with collagenous connective tissue fibers.

This text uses material from Wikipedia licensed under CC BY-SA